BIIB Operating Expenses

Biogen · Operating Expenses

BIIB logo

BIIB Operating Expenses

Latest reported$5.46B
BIIB TTM Operating Expenses ($6.30M → $5.46B)
High-resolution chart · PNG

BIIB operating expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Biogen Operating Expenses — Trailing twelve months (TTM) (USD)
Period endingOperating Expenses (USD)
5,463,100,000
5,335,000,000
5,036,100,000
4,558,300,000
4,843,800,000
4,875,200,000
4,856,700,000
4,750,100,000
5,050,100,000
5,081,100,000
5,204,900,000
5,364,100,000
4,983,200,000
4,978,300,000
5,006,000,000
5,158,000,000
5,456,500,000
6,132,300,000
6,120,800,000
7,246,600,000
7,619,700,000
7,071,200,000
7,089,300,000
5,843,200,000
5,366,400,000
5,254,900,000
5,379,900,000
5,528,100,000
5,444,900,000
5,982,700,000
5,748,000,000
5,484,900,000
5,258,200,000
5,047,100,000
5,298,100,000
5,626,200,000
5,685,900,000
5,238,100,000
4,872,100,000
4,551,700,000
4,534,200,000
4,543,200,000
4,632,400,000
4,476,773,000
4,436,902,000
4,505,342,000
4,559,900,000
4,425,598,000
4,277,922,000
3,972,217,000
3,574,949,000
3,374,723,000
3,180,122,000
3,121,103,000
3,128,660,000
3,057,485,000
2,774,976,000
2,696,191,000
2,590,690,000
2,576,302,000
3,030,595,000
3,043,101,000
3,067,271,000
2,947,667,000
2,704,785,000
2,774,602,000
2,699,815,000
2,698,629,000
2,695,396,000
2,519,988,000
2,481,907,000
2,382,419,000
2,321,206,000
2,199,633,000
2,056,653,000
1,157,005,000
1,017,969,000
1,239,359,000
1,157,783,000
1,231,448,000
1,277,561,000
1,061,738,000
1,103,965,000
1,217,400,000
1,139,898,000
1,040,162,000
998,083,000
1,822,225,000
1,480,732,000
1,168,855,000
851,267,000
373,968,000
484,675,000
588,963,000
691,568,000
665,759,000
627,710,000
581,102,000
546,575,000
514,629,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.